Jaakko Tapio Linna
Directeur Général chez Novo Nordisk Farma Oy
Profil
Jaakko Tapio Linna is currently the Chief Executive Officer at Novo Nordisk Farma Oy since 2018.
Prior to this, he was the Chief Executive Officer & Director at Takeda Oy.
Postes actifs de Jaakko Tapio Linna
| Sociétés | Poste | Début |
|---|---|---|
Novo Nordisk Farma Oy
 Novo Nordisk Farma Oy Medical/Nursing ServicesHealth Services Novo Nordisk Farma Oy provides diabetes care services. The firm also engages in development of haemophilia care, growth hormone therapy and menopausal hormone therapy. The company was founded in 1972 and is headquartered in Espoo, Finland. | Directeur Général | 02/04/2018 |
Anciens postes connus de Jaakko Tapio Linna
| Sociétés | Poste | Fin |
|---|---|---|
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | Directeur Général | 01/11/2015 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Takeda Oy manufactures pharmaceutical products. The company offers prescription and over-the-counter medicines, as well as hospital products. Its core therapeutical areas are inflammatory bowel, respiratory and cardiovascular diseases, pain management, and cancer. Takeda was founded in 1946 and is headquartered in Helsinki, Finland. | Health Technology |
Novo Nordisk Farma Oy
Novo Nordisk Farma Oy Medical/Nursing ServicesHealth Services Novo Nordisk Farma Oy provides diabetes care services. The firm also engages in development of haemophilia care, growth hormone therapy and menopausal hormone therapy. The company was founded in 1972 and is headquartered in Espoo, Finland. | Health Services |
